Quick summary: Androgen deprivation therapy (ADT) lowers estrogen by about 80 percent along with testosterone in men with prostate cancer. Low estrogen causes hot flashes, bone loss, and changes in how the body processes food and fat. Eating cruciferous vegetables and trying plant compounds like DIM – tested at doses between 108 mg and 300 mg per day in clinical trials – is one way to support the body during survivorship care.
What ADT Does to Testosterone and Estrogen
Androgen deprivation therapy lowers testosterone, the main hormone that drives most prostate cancers. GnRH agonists and antagonists reduce serum testosterone by more than 95 percent. But testosterone isn’t alone – other hormones drop too. In men, most estrogen comes from converting testosterone to estradiol through a process called aromatization. When testosterone falls sharply, estrogen falls with it. A 2024 review of estradiol loss during ADT in prostate cancer patients found that serum estradiol drops by about 80 percent in men receiving ADT.
Men need estrogen for several key body functions. Estradiol helps keep bones strong by slowing how fast bones break down. It matters for heart health and how the body handles fats. It also helps stabilize mood and thinking. When estrogen drops sharply during ADT, symptoms from low estrogen show up alongside the more common effects of low androgens.
Estrogen-Linked Side Effects of ADT
Hot flashes are the most common estrogen-linked side effect of ADT. Between 50 and 93 percent of men on ADT get hot flashes at some point, according to a published review of estrogenic side effects of ADT. The cause is the same as in women during menopause: the brain’s temperature control center loses estrogen’s calming signal and becomes too sensitive to small temperature changes, triggering sudden heat and sweating. For some men, hot flashes are mild and rare. For others, they break up sleep and get in the way of daily life.
Bone loss is a more serious long-term concern. A published review of ADT metabolic consequences found that bone mineral density can drop 4 to 13 percent each year in men receiving ADT. Over two or more years of treatment, the total bone loss can reach levels that count as osteoporosis. The risk of breaking a bone goes up with it. For more information about keeping bones strong during ADT – including how much vitamin D to take and resistance training plans – see prostate cancer ADT and bone health.
Metabolic changes are a third concern. ADT consistently cuts muscle and adds body fat. Blood sugar control often gets worse, and fat levels in the blood shift to higher triglycerides and lower HDL cholesterol. The same review noted that men on ADT face a higher risk of metabolic syndrome over time. These changes are covered in the article on managing weight gain and insulin resistance on prostate cancer ADT.
Two Pathways of Estrogen Metabolism
Not all estrogen byproducts work the same way in the body. The liver breaks down estrogen through several routes. Two of the most studied are 2-hydroxylation and 16-alpha-hydroxylation. The first makes 2-hydroxyestrone (2-OHE1). The second makes 16-alpha-hydroxyestrone (16-OHE1). These byproducts differ in how strongly they attach to estrogen receptors in tissues throughout the body.
The ratio of 2-OHE1 to 16-OHE1 has been studied as a sign of estrogen metabolism quality. A higher ratio – more 2-OHE1 compared to 16-OHE1 – seems better in hormone-sensitive tissue, based on research in women past menopause and those with BRCA1 mutations. A pilot study of DIM and urinary hormone metabolites found that 108 mg of DIM (diindolylmethane) daily for 30 days increased urinary 2-OHE1 byproducts compared to placebo in women with a history of early-stage breast cancer. Whether this shift in metabolism works the same way in men on ADT is reasonable to consider biologically but hasn’t been tested in large clinical trials in this group.
DIM and I3C: What the Research Shows
Diindolylmethane (DIM) and indole-3-carbinol (I3C) are plant compounds found in cruciferous vegetables. When you chew and digest cruciferous foods, stomach acid converts I3C into DIM. Both compounds have been studied for how they affect estrogen metabolism and how they might affect prostate cancer cells.
The pilot study mentioned above used 108 mg of DIM daily for 30 days and found changes in urinary estrogen byproduct ratios. In a separate phase I study in men who had prostate removal surgery, researchers tested an absorption-enhanced form of DIM at doses from 150 mg per day up to 300 mg per day, given as 75 mg twice daily moving up to 150 mg twice daily. That phase I dose-escalation study of DIM in prostatectomy patients found that DIM was tolerated well at those doses and showed male-hormone-blocking activity at the cell level. These are early findings – they show safety and early biological effects, not final clinical results.
For prostate cancer patients thinking about DIM and I3C as part of an integrative plan, Cruciferex Estrogen Detox combines both DIM and I3C. Doses of DIM tested in published trials range from 108 mg to 300 mg per day. The right dose and timing for you should be talked through with your oncology team – especially if you are on active ADT, since DIM shows male-hormone-blocking properties in lab and early clinical tests.
Food-Based Support for Estrogen Metabolism
Diet is a practical, easy way to get more I3C and DIM. Cruciferous vegetables are the best food sources: broccoli, cauliflower, cabbage, kale, Brussels sprouts, and bok choy. Light steaming keeps more of the glucosinolates that turn into I3C than boiling does. Eating more cruciferous vegetables has been linked to shifts in estrogen byproduct ratios in research groups, though supplement forms give more concentrated amounts than most people get from food alone.
Limit alcohol during ADT recovery. Regular alcohol use can hurt the liver’s ability to clear estrogen well, which might raise levels of circulating estrogen byproducts. Cutting back or avoiding alcohol during active treatment and into recovery is a simple, free step for men dealing with hormone disruption from ADT.
Body composition directly affects estrogen metabolism. Fat tissue has aromatase, the enzyme that turns male hormones into estrogen. Men who gain a lot of body fat during ADT – a common effect – may see estrogen levels rise from this fat-based production, even though testosterone stays low. Keeping body weight steady through diet and exercise matters not just for heart and metabolic health but also for hormone balance during and after ADT.
Exercise During and After ADT
A published clinical review of exercise and metabolic syndrome in prostate cancer patients found that regular aerobic and resistance exercise improved body composition, insulin sensitivity, and quality of life in men on ADT. Resistance training is especially key because muscle loss is a direct result of androgen suppression. Keeping muscle through resistance work helps stop the muscle loss that ADT speeds up. Combining resistance and aerobic exercise most days – rather than just one type – has shown the best results in this group. Talk with your care team about what intensity and amount is right for your current health.
Hormone Monitoring and the Recovery Window
When men stop ADT after a set course of treatment, testosterone and estrogen come back gradually. Recovery can take 3 months to more than 2 years. Being older and getting ADT for longer both slow recovery. During this time, estrogen stays low until testosterone bounces back enough for aromatization to resume.
Standard monitoring during recovery usually includes total and free testosterone, serum estradiol, bone density by DEXA scan, and fasting metabolic blood work including glucose and lipid panel. These tests give your oncology team an objective picture of hormone recovery progress. Changes in quality of life during recovery – such as libido, erectile function, and mood – often follow how quickly hormones return to normal. For a detailed look at sexual health during and after ADT recovery, see the article on prostate cancer and erectile dysfunction.
Estrogen Rebalancing as Part of Survivorship Care
Estrogen rebalancing after ADT is one part of a broader survivorship plan that handles bone health, metabolic health, heart health risk, and quality of life together. The same hormone that was lowered to slow cancer growth also protects multiple body systems. Supporting good estrogen metabolism – through diet, plant compounds tested in clinical trials, and regular exercise – may help manage several ADT side effects at once rather than treating each one separately.
Men thinking about DIM and I3C formulations as part of their survivorship plan may want to review current product options with their oncology team. See what products are available in the Nutraceuticals category to find formulations you can bring up at your next clinical visit.
If you take prescription medications, including any hormone therapies, or if you are pregnant or breastfeeding, talk to a clinician before starting any supplement. This article is for general information and is not a substitute for medical advice. Always talk with your oncologist or care team about your specific situation.
